FRTN is a sub-penny OTC stock trading at $0.09, up roughly 6% on the week but still 10% below where it was a month ago.
The honest story here is one of thin data and dormant activity. Nearly every meaningful dataset in the snapshot is stale. Short interest figures are 72 days old. Cost-to-borrow data is 84 days old. Valuation multiples date to 2021. Insider trades are from 2004 and 2005. None of that can be treated as a current read on positioning.
What the historical short interest data does show is a sharp wind-down in bearish positioning. Estimated shares short fell roughly 69% over the weeks ending mid-February, dropping from around 5,600 shares to fewer than 1,750. The ORTEX short score fell in parallel — from a peak near 36 on February 10 to just 25 by February 17. Both readings suggest shorts were closing out, not building. The most recent FINRA fortnightly figure, settled April 15, put shares short at 12,552 — a larger number, though that figure covers a different counting methodology and a different date window. The gap between the two sources is worth noting but not reconciling without fresher estimates.
The lending market looks relaxed. Availability has loosened considerably from a period in late 2025 when it hit fully used — every share in the pool lent out — on at least two separate occasions in November and December. By mid-February, availability was back above 94%, meaning the squeeze pressure that characterised late 2025 has largely dissipated. Cost to borrow has also fallen from highs above 1.2% in December to around 0.55%, confirming that demand for borrows is well off its peak.
Fortran Corporation carries no analyst coverage, no options market, no current earnings schedule, and no institutional flow data worth citing. The last earnings events on record are from 2014 and 2016 — moves of between -40% and +53% in a single session, typical for an illiquid micro-cap reacting to any material news. With market cap data absent and the float almost certainly tiny, any news event could produce outsized price action in either direction.
The stock is essentially in a quiet phase: short sellers have stepped back, borrow is cheap, and there are no known near-term catalysts. The data to watch — if and when it refreshes — is whether estimated short interest starts rebuilding and whether the ORTEX short score climbs back toward the 30s, which would signal renewed bearish interest in a name that has historically moved sharply when attention arrives.
See the live data behind this article on ORTEX.
Open FRTN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
